Kenvue Inc. (KVUE)
KVUE Q2 Earnings Miss Estimates as Margins Narrows, Sales Rise
Kenvue posts higher Q2 sales and earnings, but both miss estimates as inflation, tariffs and foreign exchange pressure margins.
Kenvue second quarter results fall short of expectations, sending shares lower
Kenvue Inc (NYSE:KVUE) shares fell about 2% on Thursday after the consumer health company reported second quarter results that narrowly missed Wall Street expectations, while margins declined from a year earlier. The company reported adjusted diluted earnings per share of $0.31, compared with the $0.32 consensus estimate.
Kenvue (KVUE) Lags Q2 Earnings and Revenue Estimates
Kenvue (KVUE) came out with quarterly earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.29 per share a year ago.
Kenvue Posts Higher Profit, Sales as Turnaround Continues
Kenvue reported higher profit and sales in the second quarter, boosted by higher prices and volumes, as the company continues working to turn around its business ahead of its acquisition by Kimberly-Clark.
Kenvue's Q2 Earnings Coming Up: Here's What Lies Ahead of the Stock
KVUE is expected to post Q2 revenue and earnings growth as brand strength, innovation and productivity efforts offset seasonal and cost pressures.
Kenvue Benefits From Consumer Health Trends and Margin Expansion
Kenvue's beauty momentum, margin expansion and stronger cash flow support its outlook as uneven demand and deal uncertainty temper visibility.
Is Kenvue Stock Attractive After Margin Gains and Deal Uncertainty
KVUE's margin gains and stronger cash flow boost its appeal, but slow organic growth, debt and deal uncertainty keep the outlook balanced.
Kenvue's Brand Strength and Growth Drivers Shape Its Future Outlook
KVUE's trusted brands, margin gains and pending Kimberly-Clark deal shape its outlook amid mixed growth signals.
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off cash, growing earnings, and reaffirming guidance.
Best Consumer Dividend Stocks to Buy Now: HAS, KVUE, MOV
Here are three top-rated consumer dividend stocks that have yields above 3% and have made their way onto the coveted Zacks Rank #1 (Strong Buy) list.
KVUE or LRLCY: Which Is the Better Value Stock Right Now?
Investors with an interest in Consumer Products - Staples stocks have likely encountered both Kenvue (KVUE) and L'Oreal SA (LRLCY). But which of these two stocks is more attractive to value investors?
Kimberly-Clark positioned for long-term value creation following Kenvue deal, says Bank of America
Kimberly-Clark Corp (NYSE:KMB, XETRA:KMY) has earned a repeat ‘Buy' rating and $120 price objective from Bank of America analysts, who believe that the company's acquisition of Kenvue assets could create long-term value despite near-term integration challenges. The analysts said the deal appears opportunistic, noting the acquisition multiple of about 14 times Kenvue's last-twelve-month adjusted EBITDA and a purchase price of $21.01 per share, roughly in line with Kenvue's market value before Tylenol-related headlines weighed on the stock in September 2025.
